Docetaxel 10 mg/mL (Docetaxel Anhydrous INJECTION) 10 mg/mL

Docetaxel 10 mg/mL is an injectable medication used for various therapeutic purposes. This intravenous solution is manufactured by Sagent Pharmaceuticals in the USA.

Strength

10 mg/mL

Pack Size

1 VIAL in 1 CARTON (25021-254-16) / 16 mL in 1 VIAL

Manufacturer / TM Owner

Sagent Pharmaceuticals

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Docetaxel 10 mg/mL is primarily used in the treatment of certain types of cancer. It works by interfering with the growth and spread of cancer cells in the body. This medication is often prescribed for conditions where other treatments have not been effective. Patients should consult their healthcare provider to understand what is Docetaxel used for in their specific case.

Side Effects

Common effects of Docetaxel 10 mg/mL may include fatigue, nausea, and hair loss. Some patients might experience more severe reactions such as low blood cell counts or allergic reactions. It is important to discuss potential side effects with a healthcare professional before starting treatment.

Precautions & Warnings

Docetaxel 10 mg/mL should be handled with care and administered by a healthcare professional. Patients with a history of severe allergic reactions to similar medications should inform their doctor. Proper storage and handling instructions should be followed to ensure the medication remains effective.

Avoid Interactions

Docetaxel 10 mg/mL may interact with other medications, including those that affect the liver or immune system. Alcohol and certain supplements might also interact with this medication. Patients should provide a complete list of all medications they are taking to their healthcare provider.

Frequently Asked Questions

Docetaxel is used in the treatment of certain types of cancer, often when other treatments have not been effective.

Docetaxel 10 mg/mL is administered intravenously by a healthcare professional.

Common side effects may include fatigue, nausea, hair loss, and low blood cell counts.

Docetaxel may interact with other medications, so it is important to consult a healthcare provider before combining treatments.

Patients with a history of severe allergic reactions to similar medications should avoid Docetaxel unless advised otherwise by a healthcare professional.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.